EXCEDRIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Excedrin, and when can generic versions of Excedrin launch?
Excedrin is a drug marketed by Haleon Us Holdings and is included in one NDA.
The generic ingredient in EXCEDRIN is acetaminophen; aspirin; caffeine. There are sixty-six drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the acetaminophen; aspirin; caffeine profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for EXCEDRIN?
- What are the global sales for EXCEDRIN?
- What is Average Wholesale Price for EXCEDRIN?
Summary for EXCEDRIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for EXCEDRIN |
| What excipients (inactive ingredients) are in EXCEDRIN? | EXCEDRIN excipients list |
| DailyMed Link: | EXCEDRIN at DailyMed |
US Patents and Regulatory Information for EXCEDRIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haleon Us Holdings | EXCEDRIN (MIGRAINE RELIEF) | acetaminophen; aspirin; caffeine | TABLET;ORAL | 020802-001 | Jan 14, 1998 | OTC | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
